Detail
| LncRNA Name | SNHG7 |
| Synonyms | SNHG7, NCRNA00061, MGC16037 |
| Region | GRCh38_9:136721366-136728184 Sequence |
| Ensembl | ENSG00000233016 |
| RefSeq | NR_003672 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | osteosarcoma |
| ICD-0-3 | C61.9 |
| Methods | qRT-PCR, Luciferase reporter assay, Western blot analysis |
| Sample | The OS cell lines (MG63, SaOS2, HOS, and 143B) and human osteoblastic cell line (hFOB1.19), The OS tissues and corresponding relative normal tissues |
| Expression Pattern | up-regulated |
| Function Description | the LncRNA SNHG7 is upregulated during the development of OS via inhibition of tumor suppressor miR-34s signals. |
| Pubmed ID | 29989838 |
| Year | 2018 |
| Title | Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma. |
| External Links |
| Links for SNHG7 | GenBank HGNC lncrnadb Noncode |
| Links for osteosarcoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.